Table 1. Summary of participant characteristics, stratified by COVID-19 outcome.
| All1 (n = 6152) |
COVID-19 composite endpoint2 (n = 1,806) |
Self-isolated3 (n = 1,776) |
Hospitalised4 (n = 49) |
Lab-confirmed COVID-195 (n = 459) |
|
|---|---|---|---|---|---|
| Age | |||||
| years, mean (SD) | 43.2 (10.6) | 41.9 (10.2) | 41.9 (10.2) | 42.6 (11.9) | 42.5 (10.2) |
| Sex | |||||
| Female | 4,789 (77.8%) | 1,416 (78.4%) | 1,397 (78.7%) | 32 (65.3%) | 333 (72.5%) |
| Male | 1,363 (22.2%) | 390 (21.6%) | 379 (21.3%) | 17 (34.7%) | 126 (27.5%) |
| Ethnic group | |||||
| Asian or Asian British | 846 (13.8%) | 267 (14.8%) | 259 (14.6%) | 12 (24.5%) | 74 (16.1%) |
| Black, African, Black British or Caribbean | 299 (4.9%) | 100 (5.5%) | 98 (5.5%) | 5 (10.2%) | 23 (5.0%) |
| Mixed or multiple ethnic groups | 149 (2.4%) | 48 (2.7%) | 48 (2.7%) | 2 (4.1%) | 14 (3.1%) |
| White | 4,667 (75.9%) | 1,330 (73.6%) | 1,313 (73.9%) | 29 (59.2%) | 331 (72.1%) |
| Another ethnic group | 162 (2.6%) | 53 (2.9%) | 50 (2.8%) | 1 (2.0%) | 16 (3.5%) |
| Prefer not to say | 29 (0.5%) | 8 (0.4%) | 8 (0.5%) | 0 (0.0%) | 1 (0.2%) |
| Household - Persons | |||||
| Lives alone | 675 (11.0%) | 205 (11.4%) | 200 (11.3%) | 6 (12.2%) | 49 (10.7%) |
| Lives with 1 or more persons | 5,477 (89.0%) | 1,601 (88.6%) | 1,576 (88.7%) | 43 (87.8%) | 410 (89.3%) |
| Household - Children | |||||
| No children | 2,338 (38.0%) | 664 (36.8%) | 654 (36.8%) | 25 (51.0%) | 168 (36.6%) |
| Has children | 3,139 (51.0%) | 937 (51.9%) | 922 (51.9%) | 18 (36.7%) | 242 (52.7%) |
| Comorbidities | |||||
| Hypertension | 537 (8.7%) | 158 (8.7%) | 157 (8.8%) | 6 (12.2%) | 35 (7.6%) |
| Diabetes | 188 (3.1%) | 57 (3.2%) | 54 (3.0%) | 6 (12.2%) | 17 (3.7%) |
| Cancer | 78 (1.3%) | 28 (1.6%) | 28 (1.6%) | 0 (0.0%) | 5 (1.1%) |
| Heart disease | 76 (1.2%) | 23 (1.3%) | 23 (1.3%) | 0 (0.0%) | 4 (0.9%) |
| Immunosuppression | 109 (1.8%) | 27 (1.5%) | 27 (1.5%) | 2 (4.1%) | 2 (0.4%) |
| Respiratory disease | 569 (9.2%) | 198 (11.0%) | 192 (10.8%) | 15 (30.6%) | 49 (10.7%) |
| Renal disease | 35 (0.6%) | 10 (0.6%) | 10 (0.6%) | 2 (4.1%) | 3 (0.7%) |
| Liver disease | 30 (0.5%) | 10 (0.6%) | 10 (0.6%) | 0 (0.0%) | 2 (0.4%) |
| Neurological disease | 64 (1.0%) | 18 (1.0%) | 18 (1.0%) | 0 (0.0%) | 3 (0.7%) |
| Obesity | 692 (11.2%) | 236 (13.1%) | 234 (13.2%) | 8 (16.3%) | 47 (10.2%) |
| None of the above | 4,200 (68.3%) | 1,192 (66.0%) | 1,173 (66.0%) | 23 (46.9%) | 317 (69.1%) |
| Prefer not to say | 97 (1.6%) | 26 (1.4%) | 25 (1.4%) | 0 (0.0%) | 8 (1.7%) |
| Tobacco smoking status | |||||
| Current or Ex-smoker within 1 year | 551 (9.0%) | 142 (7.9%) | 139 (7.8%) | 3 (6.1%) | 27 (5.9%) |
| Ex-smoker > 1 year | 1,221 (19.8%) | 361 (20.0%) | 357 (20.1%) | 7 (14.3%) | 96 (20.9%) |
| Never smoked | 4,305 (70.0%) | 1,279 (70.8%) | 1,258 (70.8%) | 38 (77.6%) | 327 (71.2%) |
| Prefer not to say | 75 (1.2%) | 24 (1.3%) | 22 (1.2%) | 1 (2.0%) | 9 (2.0%) |
Notes:
n (%) or mean (SD).
1
All participants.
2
Participants with the presence of the COVID-19 composite endpoint.
3
Participants who self-isolated due to symptoms and/or testing positive for SARS-CoV-2.
4
Participants who were hospitalised due to suspected/confirmed COVID-19.
5
Participants who have tested positive for SARS-CoV-2.